2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 34930453 | Daratumumab and venetoclax in combination with chemotherapy provide sustained molecular remission in relapsed/refractory CD19, CD20, and CD22 negative acute B lymphoblastic leukemia with KMT2A-AFF1 transcript. | 2021 Dec 20 | 1 |
| 2 | 28122742 | Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia. | 2017 Mar 16 | 1 |